A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis A Study to Assess Efficacy and Safety of Two Different Dose Regimens of RisankizumabAdministered Sub ...
A Phase 3, Randomized, Open-Label Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis A Phase 3, Randomized, Open-Label Study to Assess Efficacy and Safety of Two Different Dose Regimens ...